Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals - Image 1

£98.76

CRC Press Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals

Name: Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals
Brand: CRC Press
Price: 105.03 GBP
Availability: InStock

Allied Health Professions

Price History & Forecast

Last 22 days • 22 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 22 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £99 (17 days, 77.3%)

Price range: £99 - £105

Price levels: 2 different prices over 22 days

Description

Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals provides scientists responsible for the translation of novel biopharmaceuticals into clinical trials with a better understanding of how to navigate the obstacles that keep innovative medical research discoveries from becoming new therapies or even making it to clinical trials. The book includes sections on protein-based therapeutics, modified proteins, oligonucleotide-based therapies, monoclonal antibodies, antibody–drug conjugates, gene and cell-based therapies, gene-modified cell-based therapies, combination products, and therapeutic vaccines. Best practices are defined for efficient discovery research to facilitate a science-based, efficient, and predictive preclinical development program to ensure clinical efficacy and safety. Key Features: Defines best practices for leveraging of discovery research to facilitate a development program Includes general principles, animal models, biomarkers, preclinical toxicology testing paradigms, and practical applications Discusses rare diseases Discusses "What-Why-When-How" highlighting different considerations based upon product attributes. Includes special considerations for rare diseases About the Editors Joy A. Cavagnaro is an internationally recognized expert in preclinical development and regulatory strategy with an emphasis on genetic medicines.. Her 40-year career spans academia, government (FDA), and the CRO and biotech industries. She was awarded the 2019 Arnold J Lehman Award from the Society of Toxicology for introducing the concept of science-based, case-by-case approach to preclinical safety evaluation, which became the foundation of ICH S6. She currently serves on scientific advisory boards for advocacy groups and companies and consults and lectures in the area of preclinical development of novel therapies. Mary Ellen Cosenza is a regulatory toxicology consultant with over 30 years of senior leadership experience in the biopharmaceutical industry in the U.S., Europe, and emerging markets. She has held leadership position in both the American College of Toxicology (ACT) and the International Union of Toxicology (IUTOX) and is also an adjunct assistant professor at the University of Southern California where she teaches graduate-level courses in toxicology and regulation of biologics.

Product Specifications

Brand: CRC Press
Format: hardcover
ASIN: 0367644274
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions
Domain: Amazon UK
Release Date: 26 November 2021
Listed Since: 14 May 2021

Barcode

No barcode data available

CRC Press Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Translating Molecules into Medicines: Cross-Functional Integration at the Drug Discovery-Development Interface: 25 (AAPS Advances in the Pharmaceutical Sciences Series, 25)

Nonclinical Drug Administration: Formulations, Routes and Regimens for Solving Drug Delivery Problems in Animal Model Systems

Drug Development for Gene Therapy: Translational Biomarkers, Bioanalysis, and Companion Diagnostics

Humana Translational Toxicology - New Therapeutic Discipline

Translational ADMET for Drug Therapy: Principles, Methods, and Pharmaceutical Applications

Translational Medicine: Strategies and Statistical Methods: 28 (Chapman & Hall/CRC Biostatistics)

Drug Discovery and Development, Third Edition

Targeted Molecular Imaging (Imaging in Medical Diagnosis and Therapy)

Contract Research and Development Organizations-Their History, Selection, and Utilization

Development and Evaluation of Drugs: From Laboratory through Licensure to Market

Immunotherapy – A Novel Facet of Modern Therapeutics

Immunotherapy – A Novel Facet of Modern Therapeutics

Lost In Translation: Barriers To Incentives For Translational Research In Medical Sciences

Regulated Bioanalysis: Fundamentals and Practice: 26 (AAPS Advances in the Pharmaceutical Sciences Series, 26)

Re-inventing Drug Development - CRC Press Biopharma Book

Development of Therapeutic Agents Handbook: 8 (Pharmaceutical Development Series)

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

Clinical and Translational Science: Principles of Human Research

Basic Principles of Drug Discovery and Development

Biopharmaceuticals: Challenges and Opportunities

Transporters and Drug-Metabolizing Enzymes in Drug Toxicity

Current Topics in Nonclinical Drug Development: Volume 1

Biopharmaceuticals in Plants: Toward the Next Century of Medicine

Immune Aspects of Biopharmaceuticals and Nanomedicines (Jenny Stanford Series on Nanomedicine)